SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Frostman who wrote (10602)7/7/1998 9:36:00 AM
From: DaiS  Read Replies (1) of 23519
 
Frostman,

The scripts have been more or less stable for 5-6 weeks now. Refills have been cut by 50% indicating that viagra has taken away only 50% of vivus regulars, the remainder resistant to the viagra onslaught over several weeks. This solid bottoming is as reassuring as an upturn and susggests that muse is good and can fight viagra.

Well I think that we can get down on our knees and give thanks that it was 50% not 80% or 90%. And it shows that a large proportion of the couple of million that have tried viagra would definately be helped by muse - given the right effort by Vivus.

DaiS
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News